Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
5.22
+0.15 (2.96%)
At close: Nov 5, 2024, 4:00 PM
5.16
-0.06 (-1.15%)
After-hours: Nov 5, 2024, 6:35 PM EST
Humacyte Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
185
Market Cap
652.67M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | 1.57M | 302.00K | 23.91% |
| Dec 31, 2021 | 1.26M | -228.00K | -15.29% |
| Dec 31, 2020 | 1.49M | -4.70M | -75.90% |
| Dec 31, 2019 | 6.19M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ironwood Pharmaceuticals | 400.57M |
| Cytek Biosciences | 197.71M |
| Pacific Biosciences of California | 188.87M |
| Standard BioTools | 155.90M |
| Stoke Therapeutics | 15.16M |
| Immunome | 10.78M |
| Oculis Holding AG | 969.29K |
HUMA News
- 10 hours ago - Bronstein, Gewirtz & Grossman, LLC Encourages Humacyte, Inc. (HUMA) Investors to Inquire about Securities Investigation - Accesswire
- 1 day ago - Humacyte's (HUMA) Statements to Investors Called Into Question in Light of FDA Violations – Hagens Berman - GlobeNewsWire
- 1 day ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Humacyte, Inc. (HUMA) And Encourages Investors to Reach Out - Accesswire
- 2 days ago - Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Humacyte, Inc. (HUMA) And Encourages Stockholders to Reach Out - Accesswire
- 4 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Humacyte, Inc. (HUMA) And Encourages Stockholders to Connect - Accesswire
- 5 days ago - Humacyte, Inc. (HUMA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Accesswire
- 5 days ago - Humacyte (HUMA) Faces Questions After FDA Inspection – Hagens Berman - GlobeNewsWire
- 6 days ago - Humacyte Stock - Investors of Humacyte Encouraged to Contact Kehoe Law Firm, P.C. - HUMA - Accesswire